<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00639964</url>
  </required_header>
  <id_info>
    <org_study_id>2007/0714</org_study_id>
    <secondary_id>2007-A00534-49</secondary_id>
    <secondary_id>PHRC 2007/R1901</secondary_id>
    <secondary_id>DGS 2007-0340</secondary_id>
    <nct_id>NCT00639964</nct_id>
  </id_info>
  <brief_title>Exploration of the Lipid Metabolism During the Diabetic Pregnancies</brief_title>
  <acronym>DIAMANT</acronym>
  <official_title>Exploration of the Lipid Metabolism During the Diabetic Pregnancies and Research for New Biological Predictors to Nutritional Interventions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Justification:&#xD;
&#xD;
      Intrauterine exposure to type 1 or type 2 diabetes increase the risk of macrosomia (35 % to&#xD;
      50 % versus 10 % in general population) despite a good glycemic control. The consequences are&#xD;
      : shoulder's dystocia, lung immaturity, caesarean section, neonatal hypoglycaemia and a high&#xD;
      frequency of obesity and metabolic disorders in adults.&#xD;
&#xD;
      The mechanisms of macrosomia are unclear; chronic hyperglycemia and subsequent&#xD;
      hyperinsulinaemia observed during the diabetic pregnancy might explain only partially the&#xD;
      fetal weight. Considerable interest has been generated over the last decade on the lipids and&#xD;
      fatty acids alterations in diabetes pregnancies. Change in lipoproteins metabolism have been&#xD;
      described associated with macrosomia. Maternal nutrition before and during pregnancy plays an&#xD;
      important role in fetal growth and subsequent development of an increased susceptibility to&#xD;
      obesity and diabetes in later life.&#xD;
&#xD;
      Main objective:&#xD;
&#xD;
      Looking for an association between maternal and fetal blood lipid parameters and birth weight&#xD;
      and body fat in a context of type 1 or type 2 diabetes.&#xD;
&#xD;
      Secondary objectives:&#xD;
&#xD;
        -  Identify lipid markers associated with fetal macrosomia.&#xD;
&#xD;
        -  Analyze the placenta by measuring the expression of genes implicated in the storage and&#xD;
           the transfer of fatty acids.&#xD;
&#xD;
        -  Analyze and compare the expression level of placental genes subjected to parental&#xD;
           imprinting and validated in animal models.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Plan of study:&#xD;
&#xD;
      Longitudinal study on 3 groups: 70 type 1 diabetic women, 70 type 2 diabetic women and 70&#xD;
      women with normal glucose tolerance during pregnancy. Recruitment in the department of&#xD;
      Diabetology and Obstetrics of CHRU of Amiens and Lille.&#xD;
&#xD;
      Nutritional survey and sampling of blood in the 1st, 2nd and 3rd trimester of pregnancy and&#xD;
      at 6 weeks post partum.&#xD;
&#xD;
      Collection of cord blood and placental tissues. Histological and molecular analysis of&#xD;
      placenta will be realized both in the departments of Anatomopathology of Lille and Amiens and&#xD;
      in Biochemistry Molecular Biology of CHRU of Lille.&#xD;
&#xD;
      Homocysteine and folate assays on cord blood will be centralized in Paris (Hospital St&#xD;
      Louis).&#xD;
&#xD;
      Main criteria of judgment&#xD;
&#xD;
      Fetal weight corrected by the gestational age.&#xD;
&#xD;
      Expected results:&#xD;
&#xD;
        -  An inverse correlation between maternal and fetal blood fatty acids ratios&#xD;
           (polyunsaturated fatty acids/ monounsaturated fatty acids + saturated) and birth weight&#xD;
           in the diabetic groups.&#xD;
&#xD;
        -  Differences of distribution of fatty acids of maternal and foetal erythrocytic&#xD;
           phospholipids correlated with the fetal weight.&#xD;
&#xD;
        -  Qualitative and quantitative variations of expression of placental genes such as lipases&#xD;
           and genes submitted to parental imprinting.&#xD;
&#xD;
      The biologic parameters will be confronted with the data of the nutritional survey and with&#xD;
      glycemic control during pregnancy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>fetal weight corrected by gestational age</measure>
    <time_frame>just after delivery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>cholesterol (total, HDL, LDL)</measure>
    <time_frame>3 measures during pregnancy and 1 at post partum, 1 measure at time of delivery from fetal cord</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>triglycerides</measure>
    <time_frame>3 measures during pregnancy and 1 at post partum, 1 measure at time of delivery from fetal cord</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apolipoprotein A/B rate</measure>
    <time_frame>3 measures during pregnancy and 1 at post partum, 1 measure at time of delivery from fetal cord</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>erythrocytary and plasmatic fatty acid distribution</measure>
    <time_frame>3 measures during pregnancy and 1 at post partum, 1 measure at time of delivery from fetal cord</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">186</enrollment>
  <condition>Pregnancy</condition>
  <condition>Pregnancy in Diabetes</condition>
  <condition>Type 1 Diabetes Mellitus</condition>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>type 1 diabetic pregnant women</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>type 1 diabetic pregnant women</description>
  </arm_group>
  <arm_group>
    <arm_group_label>type 2 diabetic pregnant women</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>type 2 diabetic pregnant women</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy pregnant women</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>healthy pregnant women with normal glucose tolerance</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood tests</intervention_name>
    <description>3 measures during pregnancy and 1 at post partum, 1 measure at time of delivery from fetal cord</description>
    <arm_group_label>healthy pregnant women</arm_group_label>
    <arm_group_label>type 1 diabetic pregnant women</arm_group_label>
    <arm_group_label>type 2 diabetic pregnant women</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>diet questionnaire</intervention_name>
    <description>questions about nutrition before and during pregnancy</description>
    <arm_group_label>healthy pregnant women</arm_group_label>
    <arm_group_label>type 1 diabetic pregnant women</arm_group_label>
    <arm_group_label>type 2 diabetic pregnant women</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>umbilical cord blood collect</intervention_name>
    <description>collected at the delivery</description>
    <arm_group_label>healthy pregnant women</arm_group_label>
    <arm_group_label>type 1 diabetic pregnant women</arm_group_label>
    <arm_group_label>type 2 diabetic pregnant women</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placenta collect</intervention_name>
    <description>collected at the delivery</description>
    <arm_group_label>healthy pregnant women</arm_group_label>
    <arm_group_label>type 1 diabetic pregnant women</arm_group_label>
    <arm_group_label>type 2 diabetic pregnant women</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  pregnant women included before 16 amenorrhea weeks&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  obesity (BMI &gt; 40kg/m2)&#xD;
&#xD;
          -  subject became pregnant with medical infertility treatment&#xD;
&#xD;
          -  tobacco &gt; 10&#xD;
&#xD;
          -  suspected abuse of alcohol&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne VAMBERGUE, MDPHD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Isabelle FAJARDY, PharmD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Univesity Hospital, Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Annie MARTIN, PharmD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gilbert BRIAND, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean ROUSSEAUX, MDPhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Damien SUBTIL, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Philippe DUFOUR, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pierre FONTAINE, MDPHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Philippe DERUELLE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Salha FENDRI, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Amiens University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fran√ßoise LE GOUEFF, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier de Roubaix</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Delphine VINCENT-DESPLANQUE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier de Roubaix</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lucie BRESSON, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lille University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eleonore DELARUE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Odile GAGNEUR, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Lille</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHRU, Lille</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <study_first_submitted>March 14, 2008</study_first_submitted>
  <study_first_submitted_qc>March 19, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 20, 2008</study_first_posted>
  <last_update_submitted>May 31, 2016</last_update_submitted>
  <last_update_submitted_qc>May 31, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diabetes</keyword>
  <keyword>pregnancy</keyword>
  <keyword>macrosomia</keyword>
  <keyword>lipidics markers</keyword>
  <keyword>nutritional factors</keyword>
  <keyword>placenta</keyword>
  <keyword>umbilical blood cord</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregnancy in Diabetics</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

